विवरण

Clinical remission rates in ulcerative colitis patients receiving curcumin alongside standard therapy are compared to control groups. Pooled data suggest a favorable trend for the curcumin-supplemented group.

Figure 3

Forest Plot

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 3: Clinical remission rates in ulcerative colitis patients receiving curcumin alongside standard therapy are compared to control groups. Pooled data suggest a favorable trend for the curcumin-supplemented group.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Clinical remission rates in ulcerative colitis patients receiving curcumin alongside standard therapy are compared to control groups. Pooled data suggest a favorable trend for the curcumin-supplemented group." />
  <figcaption>Figure 3. Clinical remission rates in ulcerative colitis patients receiving curcumin alongside standard therapy are compared to control groups. Pooled data suggest a favorable trend for the curcumin-supplemented group.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

विवरण

Figure 3

Source Paper

Cite This Figure

संबंधित साक्ष्य